NDLVC management requires a paradigm shift towards a multi-parametric, genotype-directed framework, where cardiac magnetic resonance tissue characterisation and personalized risk scores are essential to optimize sudden cardiac death prevention.
C. Castelli, R. Rossini, A. Maffè et al.· Cardiogenetics· 0 citations
PURPOSE
Emerging evidence points on an increased mortality risk associated to moderate aortic stenosis (AS), yet this population remains insufficiently characterized. We tested the prognostic value of two echocardiographic coupling indices reflecting right and left-sided cardiac function: the ratio of tricuspid annular...
G. Santangelo, A. Faggiano, G. Mallardi et al.· International Journal of Car...· 0 citations
Summary Hypertrophic cardiomyopathy (HCM) is a genetically determined heart disease characterized by marked clinical heterogeneity and limited availability of specific circulating biomarkers that reflect underlying disease mechanisms. This study investigated whether plasma-derived extracellular vesicles (EVs) capture d...
A. Rizzuto, Andrea Faggiano, C. Macchi et al.· iScience· 0 citations
The meta-analysis suggests that the high contemporary prevalence of LVH reflects the failure of therapeutic strategies worldwide in the prevention and treatment of HHD, and implies the need for a more aggressive treatment of hypertension and related cardiovascular risk factors leading to LVH, especially in women.
E. Gherbesi, Andrea Faggiano, Carla Sala et al.· Journal of Hypertension· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.